scholarly journals Use of Real-Time Continuous Glucose Monitoring (rtCGM) Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy

2021 ◽  
Author(s):  
Thomas Grace ◽  
Jay Slyer
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Real Time ◽  
Clinical Outcomes ◽  
Continuous Glucose Monitoring ◽  
Intensive Therapy ◽  
Glucose Monitoring ◽  
Diabetes Patients

scholarly journals The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus

2011 ◽  
Vol 5 (3) ◽  
pp. 668-675 ◽  
Author(s):  
Nicole M. Ehrhardt ◽  
Mary Chellappa ◽  
M. Susan Walker ◽  
Stephanie J. Fonda ◽  
Robert A. Vigersky
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Real Time ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring

924-P: Pattern Mining of Trajectories of Glucose Values of Continuous Glucose Monitoring System by Artificial Intelligence in Type 2 Diabetes Patients

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 924-P
Author(s):  
MASAKI MAKINO ◽  
RYO YOSHIMOTO ◽  
MIZUHO KONDO-ANDO ◽  
YASUMASA YOSHINO ◽  
IZUMI HIRATSUKA ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Type 2 Diabetes ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Pattern Mining ◽  
Glucose Monitoring ◽  
Continuous Glucose Monitoring System ◽  
Diabetes Patients

2180-PUB: Integration of Continuous Glucose Monitoring in Diabetes Self-Management Education for Type 2 Diabetes Improves Glycemic Control

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 2180-PUB
Author(s):  
ADDIE L. FORTMANN ◽  
ALESSANDRA BASTIAN ◽  
CODY J. LENSING ◽  
SHANE HOVERSTEN ◽  
KIMBERLY LUU ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Continuous Glucose Monitoring ◽  
Management Education ◽  
Glucose Monitoring ◽  
Self Management

scholarly journals The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Dulce Adelaida Rivera-Ávila ◽  
Alejandro Iván Esquivel-Lu ◽  
Carlos Rafael Salazar-Lozano ◽  
Kyla Jones ◽  
Svetlana V. Doubova
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Outcome Variable ◽  
Control Group ◽  
Educational Tool ◽  
Study Objective ◽  
Hba1c Levels

Abstract Background The study objective was to evaluate the effects of professional continuous glucose monitoring (CGM) as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes (T2D). Methods We conducted a three-month quasi-experimental study with an intervention (IGr) and control group (CGr) and ex-ante and ex-post evaluations in one family medicine clinic in Mexico City. Participants were T2D patients with HbA1c > 8% attending a comprehensive diabetes care program. In addition to the program, the IGr wore a professional CGM sensor (iPro™2) during the first 7 days of the study. Following this period, IGr participants had a medical consultation for the CGM results and treatment adjustments. Additionally, they received an educational session and personalized diet plan from a dietitian. After 3 months, the IGr again wore the CGM sensor for 1 week. The primary outcome variable was HbA1c level measured at baseline and 3 months after the CGM intervention. We analyzed the effect of the intervention on HbA1c levels by estimating the differences-in-differences treatment effect (Diff-in-Diff). Additionally, baseline and three-month CGM and dietary information were recorded for the IGr and analyzed using the Student’s paired t-test and mixed-effects generalized linear models to control for patients’ baseline characteristics. Results Overall, 302 T2D patients participated in the study (IGr, n = 150; control, n = 152). At the end of the three-month follow-up, we observed 0.439 mean HbA1C difference between groups (p = 0.004), with an additional decrease in HbA1c levels in the IGr compared with the CGr (Diff-in-Diff HbA1c mean of − 0.481% points, p = 0.023). Moreover, compared with the baseline, the three-month CGM patterns showed a significant increase in the percentage of time in glucose range (+ 7.25; p = 0.011); a reduction in the percentage of time above 180 mg/dl (− 6.01; p = 0.045), a decrease in glycemic variability (− 3.94, p = 0.034); and improvements in dietary patterns, shown by a reduction in total caloric intake (− 197.66 Kcal/day; p = 0.0001). Conclusion Professional CGM contributes to reducing HbA1c levels and is an adjuvant educational tool that can improve glycemic control in patients with T2D. Trial registration ClinicalTrials.gov: NCT04667728. Registered 16/12/2020

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

JAMA ◽  
2021 ◽  
Vol 326 (13) ◽  
pp. 1330
Author(s):  
Wellbert Hernández-Núñez ◽  
Jesús Zacarías Villareal-Pérez ◽  
René Rodríguez-Gutiérrez
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Continuous Glucose Monitoring ◽  
Basal Insulin ◽  
Glucose Monitoring

scholarly journals Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic

2020 ◽  
Author(s):  
Richard M. Bergenstal ◽  
Jennifer E. Layne ◽  
Howard Zisser ◽  
Robert A. Gabbay ◽  
Nathan A. Barleen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Real Time ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Diabetes Clinic
Sign in / Sign up

Export Citation Format

Share Document